Answers are grounded in this paper and cite their sources.
BACKGROUND: Tuberculosis (TB) remains under-diagnosed in people living with HIV (PLHIV) and is a major cause of mortality in these population. Sputum is the primary specimen for TB diagnosis; however, many PLHIV are unable to produce quality sputum. This study assessed the diagnostic utility of alternative non-invasive specimens, stool, and urine, for TB detection in PLHIV using the Xpert MTB/RIF Ultra assay. METHODS: A cross-sectional study was conducted in TB screening and treatment centres in Conakry, Guinea, including 300 PLHIV presumptive pulmonary TB. Sputum, stool, and urine specimens were collected and tested using the Xpert MTB/RIF Ultra assay. Diagnostic performance was assessed in terms of sensitivity, specificity, and positive and negative predictive values, with their 95% confidence intervals, using the sputum Xpert MTB/RIF Ultra results on as the reference standard. Agreement between specimen results was assessed using Cohen's kappa. Substantial agreement was observed between stool and sputum results (kappa = 0.77; p < 0.001). CONCLUSIONS: Xpert MTB/RIF Ultra assay demonstrated high diagnostic performance on stool specimens in PLHIV, with sensitivity surpassing that of urine specimens. Stool testing could serve as a complementary diagnostic approach, particularly for patients unable to produce sputum, thereby improving TB detection in PLHIV. Integrating stool testing into national TB diagnostic algorithms could enhance case detection and management in PLHIV, although implementation must be assessed for technical feasibility and cost-effectiveness. TRIAL REGISTRATION: Not applicable.
No takes yet. Share an insight, caveat, or question.
Diallo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: